Tcr2 Therapeutics Volatility
TCRRDelisted Stock | USD 1.48 0.00 0.00% |
We have found twenty-five technical indicators for Tcr2 Therapeutics, which you can use to evaluate the volatility of the company. Please validate Tcr2 Therapeutics' Semi Deviation of 3.26, risk adjusted performance of 0.0629, and Coefficient Of Variation of 1404.52 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Tcr2 Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Tcr2 Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Tcr2 daily returns, and it is calculated using variance and standard deviation. We also use Tcr2's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Tcr2 Therapeutics volatility.
Tcr2 |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Tcr2 Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Tcr2 Therapeutics at lower prices. For example, an investor can purchase Tcr2 stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Tcr2 Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Tcr2 Stock
0.82 | EC | Ecopetrol SA ADR | PairCorr |
0.66 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.63 | SHG | Shinhan Financial | PairCorr |
0.55 | WF | Woori Financial Group | PairCorr |
0.53 | TLK | Telkom Indonesia Tbk | PairCorr |
0.49 | HYMTF | Hyundai Motor | PairCorr |
0.48 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.39 | VFSWW | VinFast Auto | PairCorr |
0.34 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Tcr2 Therapeutics Market Sensitivity And Downside Risk
Tcr2 Therapeutics' beta coefficient measures the volatility of Tcr2 stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Tcr2 stock's returns against your selected market. In other words, Tcr2 Therapeutics's beta of -0.61 provides an investor with an approximation of how much risk Tcr2 Therapeutics stock can potentially add to one of your existing portfolios. Tcr2 Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tcr2 Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tcr2 Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Tcr2 Therapeutics Demand TrendCheck current 90 days Tcr2 Therapeutics correlation with market (Dow Jones Industrial)Tcr2 Beta |
Tcr2 standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Tcr2 Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Tcr2 Therapeutics' daily returns or price. Since the actual investment returns on holding a position in tcr2 stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Tcr2 Therapeutics.
Tcr2 Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Tcr2 Therapeutics delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Tcr2 Therapeutics' price changes. Investors will then calculate the volatility of Tcr2 Therapeutics' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Tcr2 Therapeutics' volatility:
Historical Volatility
This type of delisted stock volatility measures Tcr2 Therapeutics' fluctuations based on previous trends. It's commonly used to predict Tcr2 Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Tcr2 Therapeutics' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Tcr2 Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Tcr2 Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days Tcr2 Therapeutics has a beta of -0.606 . This usually implies as returns on the benchmark increase, returns on holding Tcr2 Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Tcr2 Therapeutics is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tcr2 Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tcr2 Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tcr2 delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Tcr2 Therapeutics has an alpha of 0.4374, implying that it can generate a 0.44 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
Returns |
What Drives a Tcr2 Therapeutics Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Tcr2 Therapeutics Stock Return Volatility
Tcr2 Therapeutics historical daily return volatility represents how much of Tcr2 Therapeutics delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7608% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About Tcr2 Therapeutics Volatility
Volatility is a rate at which the price of Tcr2 Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Tcr2 Therapeutics may increase or decrease. In other words, similar to Tcr2's beta indicator, it measures the risk of Tcr2 Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Tcr2 Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor therapies for patients suffering from cancer. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Tcr2 Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Tcr2 Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Tcr2 Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Tcr2 Therapeutics' price varies over time.
3 ways to utilize Tcr2 Therapeutics' volatility to invest better
Higher Tcr2 Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Tcr2 Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Tcr2 Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Tcr2 Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Tcr2 Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Tcr2 Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Tcr2 Therapeutics Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.76 and is 9.223372036854776E16 times more volatile than Tcr2 Therapeutics. Compared to the overall equity markets, volatility of historical daily returns of Tcr2 Therapeutics is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use Tcr2 Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Tcr2 Therapeutics to be traded at $1.4652 in 90 days.Good diversification
The correlation between Tcr2 Therapeutics and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Tcr2 Therapeutics Additional Risk Indicators
The analysis of Tcr2 Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Tcr2 Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Tcr2 Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | 0.0629 | |||
Market Risk Adjusted Performance | (0.61) | |||
Mean Deviation | 3.16 | |||
Semi Deviation | 3.26 | |||
Downside Deviation | 3.92 | |||
Coefficient Of Variation | 1404.52 | |||
Standard Deviation | 5.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Tcr2 Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Tcr2 Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Tcr2 Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Tcr2 Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Tcr2 Therapeutics.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Tcr2 Stock
If you are still planning to invest in Tcr2 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tcr2 Therapeutics' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies |